SABS:NASDAQ
SAB Biotherapeutics Inc
$3.86
arrow_upward
+5.46%(+0.20) 1D
$3.84
arrow_downward
-0.52% (-0.020)bedtimeAfter hours
Closed: Jun 17, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
$3.72
High
$3.89
Low
$3.66
Mkt. cap
295.15M
Avg. vol.
1.04M
Volume
0.00
52-wk high
$6.60
52-wk low
$1.65
EPS
-$1.43
Beta
0.54
Shares outstanding
76.46M
No. of employees
86
Open
$3.72
High
$3.89
Low
$3.66
Mkt. cap
295.15M
Avg. vol.
1.04M
Volume
0.00
52-wk high
$6.60
52-wk low
$1.65
EPS
-$1.43
Beta
0.54
Shares outstanding
76.46M
No. of employees
86
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to SABS in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for SABS in the last 3 months.
Highest
Current $3.86
$16.00 (+314.51%)
Average
$12.00 (+210.88%)
Lowest
$6.00 (+55.44%)
News stories
From sources across the web
Investing.com
·
2 days ago
Jefferies raises SAB Biotherapeutics price target on FDA approval
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Websitesab.bio
AI content may include mistakes. Learn more